CJC-1295 + Ipamorelin 5 / 5 mg, TB-500 10 mg, BPC-157 10 mg and Ipamorelin 10 mg, supplied together.
RFID on every vial. Hold it to the back of your phone and its certificate of analysis opens automatically.
Each vial ships with the certificate for its own lot.
CJC-1295 + Ipamorelin 5 / 5 mg, TB-500 10 mg, BPC-157 10 mg and Ipamorelin 10 mg, supplied together.
As a set they cost $173.48, and each vial ships with its own lot-matched certificate.
Each vial in the stack follows its own storage guidance, shown on its product page.
Handle in a laboratory setting using appropriate protective equipment. Consult the certificate of analysis and safety data for lot-specific information.
CJC-1295 + Ipamorelin is a single lyophilized vial containing 5 mg of CJC-1295 without DAC (modified GRF 1-29, a GHRH analogue) and 5 mg of ipamorelin (a ghrelin-receptor agonist). The two peptides act on different receptors on the same pituitary cells, and studies combining GHRH with GH-releasing peptides have reported synergistic growth hormone (GH) release. No published study has tested this exact combination.
TB-500 is a synthetic seven-amino-acid peptide, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ), that corresponds to residues 17 to 23 of thymosin beta-4 with an acetylated N-terminus. That short stretch contains thymosin beta-4's actin-binding motif, the region linked to cell migration and angiogenesis. TB-500 is not the full 43-amino-acid protein: much of the research quoted for it was done with full-length thymosin beta-4, and studies of the fragment itself are few and preclinical.
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide whose sequence, GEPPPGKPADDAGLV, is a partial sequence of a protein found in human gastric juice. It is one of the most-studied research peptides in tissue-repair models, with most of the work done in rats on tendon, ligament, muscle and gastrointestinal injury. Human data are limited to three small uncontrolled studies, and BPC-157 is not an approved drug.
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that releases growth hormone (GH) by activating the growth hormone secretagogue receptor, the receptor for the stomach hormone ghrelin. Novo Nordisk researchers described it in 1998 as the first selective GH secretagogue because, in swine, it raised GH without the ACTH and cortisol increases seen with GHRP-2 and GHRP-6. It reached a phase 2 trial for postoperative ileus but is not an approved medicine; it is sold for laboratory research only.
BPC-157 10 mg, TB-500 10 mg and Ipamorelin 10 mg, supplied together.
CJC-1295 + Ipamorelin 5 / 5 mg, Sermorelin 10 mg and Ipamorelin 10 mg, supplied together.
GLOW Blend 70 mg, GHK-Cu 100 mg and KPV 10 mg, supplied together.
GLP2-TZ 10 mg, 5-Amino-1MQ 50 mg and Tesamorelin 10 mg, supplied together.
Operated by DND Wellness LLC · 1309 Coffeen Ave, Suite 1200, Sheridan, WY 82801.
support@peptides-only.com · (508) 404-8124
Use the chat widget to ask a question. Informational and promotional text messages require separate, optional consent. Message frequency varies. Msg & data rates may apply. Reply STOP to unsubscribe or HELP for help. Consent is not a condition of purchase. 21+.
SMS consent & support · SMS terms & Terms of Service · Privacy Policy